Table 11.
Other reported adverse events
| Condition | Observations | Treatment |
|---|---|---|
| Hypertension | 1 | UP446 250 mg |
| Varicose veins | 1 | UP446 250 mg |
| Fluid in knee | 1 | UP446 250 mg |
| Reduced flexibility | 1 | Placebo |
| Psoriasis | 2 | UP446 250 and 500 mg |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.